Risk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014–2021

被引：0
|
作者：
Rasmus Birkholm Grønnemose
Per Syrak Hansen
Søren Worsøe Laursen
Oke Gerke
Jakob Kjellberg
Jesper Lykkegaard
Clara Thye-Rønn
Poul Flemming Høilund-Carlsen
Peter Thye-Rønn
机构：
[1] Odense University Hospital,Diagnostic Centre, Svendborg Hospital
[2] The Danish Cancer Society,Department of Nuclear Medicine
[3] Odense University Hospital,Department of Clinical Research, Faculty of Health Sciences
[4] University of Southern Denmark,VIVE
[5] The Danish Centre for Social Science Research,Research Unit of General Practice
[6] University of Southern Denmark,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1304 / 1315
页数：11
相关论文
共 50 条
  • [41] Algorithm Assignment to Stereotactic Body Radiation Therapy Is Associated with High Risk of Post-Surgical Serious Adverse Events in Stage I Non-small Cell Lung Cancer Patients
    Samson, P.
    Roach, M. C., Jr.
    Carpenter, L.
    Bradley, J. D.
    Kozower, B.
    Puri, V.
    Meyers, B.
    Robinson, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E530 - E531
  • [42] Disparities in referral by risk profile for genetic counseling of high-risk individuals: A disease-specific analysis of mutation frequencies of 1,193 patients presenting for presumptive hereditary breast ovarian cancer (HBOC) or colorectal cancer syndromes (CCS).
    Shapira, I.
    Gralla, R. J.
    Sultan, K. S.
    John, V. S.
    Devoe, C. E.
    D'Olimpio, J. T.
    Raftopoulos, H.
    Donahue, L.
    Vinciguerra, V.
    Cohen, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning
    Chang, Tzu-Hao
    Chen, Yu-Da
    Lu, Henry Horng-Shing
    Wu, Jenny L.
    Mak, Katelyn
    Yu, Cheng-Sheng
    MEDICINE, 2024, 103 (07) : E37112
  • [44] Advanced breast cancer at presentation (ABC-p) in octogenarian women (OW): Specific elderly-devoted risk tests(SEDRT) (CARG plus CRASH) as new tools to prevent serious/irreversible adverse reactions (AR) in frail patients.
    Carreca, Ignazio Ugo
    Bazan, Viviana
    Galvano, Antonio
    Carreca, Anna Paola
    Cusenza, Stefania
    Russo, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] DEPRESSIVE SYMPTOMS AND RISK OF CANCER-SPECIFIC MORTALITY AMONG OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA: ANALYSES FROM THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) MEDICARE HEALTH OUTCOMES SURVEY (MHOS)
    Asfaw, A. A.
    Talon, B.
    Nabulsi, N.
    Alobaidi, A.
    Zhou, J.
    Sweiss, K.
    Patel, P.
    Chiu, B.
    Calip, G. S.
    VALUE IN HEALTH, 2019, 22 : S89 - S89
  • [46] MEASURING DISEASE AND TREATMENT-RELATED SYMPTOMS AND HRQOL IMPACTS IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC) USING THE EORTC QLQ-C30 AND NMIBC-24: QUALITATIVE LITERATURE REVIEW AND GAP ANALYSIS
    Mason, B.
    Eccleston, A.
    Ayala, Nunes L.
    Chandrasekar, S.
    Leventi, A.
    Gater, A.
    Chang, J.
    VALUE IN HEALTH, 2024, 27 (06) : S327 - S328
  • [47] EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin
    Cambier, Samantha
    Sylvester, Richard J.
    Collette, Laurence
    Gontero, Paolo
    Brausi, Maurizio A.
    van Andel, George
    Kirkels, Wim J.
    Da Silva, Fernando Calais
    Oosterlinck, Willem
    Prescott, Stephen
    Kirkali, Ziya
    Powell, Philip H.
    de Reijke, Theo M.
    Turkeri, Levent
    Collette, Sandra
    Oddens, Jorg
    EUROPEAN UROLOGY, 2016, 69 (01) : 60 - 69
  • [48] Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (01): : 39 - 40
  • [49] Re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9
    Williams, Stephen B.
    Kamat, Ashish M.
    EUROPEAN UROLOGY, 2016, 69 (06) : E121 - E122
  • [50] Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9
    Sylvester, Richard
    Gontero, Paolo
    Oddens, Jorg
    EUROPEAN UROLOGY, 2016, 69 (06) : E123 - E124
12345